| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5695105 | Gynecologic Oncology | 2017 | 7 Pages |
Abstract
TFMV activity and plasma TF level were not predictive of VTE in this patient population. Given the extensive expression of TF in OCCC tumors, it is unlikely IHC expression will be useful in risk stratification for VTE in this population.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Joshua G. Cohen, Emily Prendergast, Julia E. Geddings, Ann E. Walts, Hasmik Agadjanian, Yohei Hisada, Beth Y. Karlan, Nigel Mackman, Christine S. Walsh,